ACTRN12605000001695已完成2 期
A phase II trial of gemcitabine in a fixed dose rate infusion combined with cisplatin in patients with operable biliary tract carcinomas with the primary objective tumour response
AGITG/ NHMRC Clinical Trials Centre0 个研究点目标入组 45 人开始时间: 2005年7月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- All
入选标准
- •Histologic or cytologic diagnosis of adenocarcinogen of the gallbladder or intra/extrahepatic bile ducts with locally advanced or metastatic disease that is not amenable to curative surgical resection or with recurrent disease after prior surgical resection or radiotherapy. Measurable disease.
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
2 期
Phase II trial of gemcitabine monotherapy in the third or further line for pretreated patients with advanced non-small cell lung canceron-small cell lung cancerJPRN-UMIN000017791Dept.Repiratory Medicine, Osaka Police Hospital21
已完成
2 期
Phase 2 study of fix dose rate gemcitabine plus S-1 with advanced biliary tract cancer refractory to standard dose rate gemcitabineJPRN-UMIN000005918Yokohama Clinical Oncology Group40
已完成
2 期
Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001)Pancreatic cancerJPRN-UMIN000003658kanagawa cancer center66
进行中（未招募）
不适用
Phase II trial of the addition of gemcitabine to 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastomarelapsed or progressive neuroblastoma in pediatric patients of 1 to 18 yearsEUCTR2007-007974-45-DEAMC47
已完成
2 期
Randomized controlled phase II trial of gemcitabine/radiation combination therapy and gemcitabine monotherapy in locally advanced pancreatic cancer.locally advanced unresectable pancreatic cancerJPRN-UMIN000000624First Dept. Internal Medicine Gifu University Hospital60